PL373594A1 - Ul16 binding protein 4 - Google Patents

Ul16 binding protein 4

Info

Publication number
PL373594A1
PL373594A1 PL02373594A PL37359402A PL373594A1 PL 373594 A1 PL373594 A1 PL 373594A1 PL 02373594 A PL02373594 A PL 02373594A PL 37359402 A PL37359402 A PL 37359402A PL 373594 A1 PL373594 A1 PL 373594A1
Authority
PL
Poland
Prior art keywords
ulbp4
binding protein
cells
encoding
vectors
Prior art date
Application number
PL02373594A
Other languages
English (en)
Polish (pl)
Inventor
David J. Cosman
Original Assignee
Immunex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corporation filed Critical Immunex Corporation
Publication of PL373594A1 publication Critical patent/PL373594A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL02373594A 2001-10-04 2002-10-04 Ul16 binding protein 4 PL373594A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32725201P 2001-10-04 2001-10-04

Publications (1)

Publication Number Publication Date
PL373594A1 true PL373594A1 (en) 2005-09-05

Family

ID=23275763

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02373594A PL373594A1 (en) 2001-10-04 2002-10-04 Ul16 binding protein 4

Country Status (10)

Country Link
US (2) US7563450B2 (enExample)
EP (1) EP1451333B1 (enExample)
JP (1) JP2005523681A (enExample)
AT (1) ATE434624T1 (enExample)
AU (1) AU2002340118B2 (enExample)
CA (1) CA2462790A1 (enExample)
DE (1) DE60232742D1 (enExample)
MX (1) MXPA04003057A (enExample)
PL (1) PL373594A1 (enExample)
WO (1) WO2003029436A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225093A1 (en) * 2002-04-22 2003-11-03 Fred Hutchinson Cancer Research Center Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
WO2004022706A2 (en) * 2002-09-04 2004-03-18 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor
US7666417B2 (en) * 2003-04-22 2010-02-23 Fred Hutchinson Cancer Research Center Methods and compositions for treating autoimmune diseases or conditions
US7834155B2 (en) 2003-07-21 2010-11-16 Immunogen Inc. CA6 antigen-specific cytotoxic conjugate and methods of using the same
HRP20110302T1 (hr) * 2003-07-21 2011-06-30 Immunogen Ca6 antigen-specifični citotoksični konjugat i postupci za njegovu uporabu
US7998481B2 (en) 2004-04-05 2011-08-16 The Regents Of The University Of California Modulation of NKG2D for treating or preventing solid organ allograft rejection
DE102004042894A1 (de) * 2004-08-30 2006-03-02 Eberhard-Karls-Universität Tübingen Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen
US20060110398A1 (en) * 2004-11-24 2006-05-25 Schering Corporation DAP-10 and uses thereof
US9593347B2 (en) 2010-04-16 2017-03-14 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
US20130156808A1 (en) * 2011-11-22 2013-06-20 Stipan Jonjic Vaccine comprising beta-herpesvirus
AU2014229476B2 (en) 2013-03-15 2019-07-11 Novelogics Biotechnology, Inc. Antibodies to MICA and MICB proteins
ES2810800T3 (es) 2013-10-28 2021-03-09 Univ Pittsburgh Commonwealth Sys Higher Education Vector de HSV oncolítico
JP2019508063A (ja) 2016-01-27 2019-03-28 オンコラス， インコーポレイテッド 腫瘍溶解性ウイルスベクター及びその使用
EP3468588A4 (en) 2016-06-14 2019-12-11 University of Pittsburgh - of The Commonwealth System of Higher Education EXPRESSION OF NKG2D-ACTIVATING LIGAND PROTEINS FOR THE SENSITIZATION OF CANCER CELLS FOR THE ATTACK THROUGH CYTOTOXIC IMMUNOCELLS
EP3478321A4 (en) 2016-06-30 2020-04-22 Oncorus, Inc. Pseudotyped oncolytic viral delivery of therapeutic polypeptides
AU2017344411A1 (en) 2016-10-19 2019-05-09 Novelogics Biotechnology, Inc. Antibodies to MICA and MICB proteins
WO2019023483A1 (en) 2017-07-26 2019-01-31 Oncorus, Inc. ONCOLYTIC VIRAL VECTORS AND USES THEREOF
EP3661537A4 (en) * 2017-08-03 2021-06-09 The Cleveland Clinic Foundation ENHANCED PEPTIDIC EXPRESSION AND DETECTION OF APO-H SPECIFIC SUBJECT ANTIBODIES
JP2021508477A (ja) 2017-12-29 2021-03-11 オンコラス， インコーポレイテッド 治療用ポリペプチドの腫瘍溶解性ウイルス送達
CN112285360B (zh) * 2020-09-23 2023-08-22 台州市第一人民医院 I-309在制备原发性干燥综合征诊断试剂或试剂盒中的应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311A (en) * 1845-12-16 William beebe
US22239A (en) * 1858-12-07 Limekiln
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
DE4118120A1 (de) 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US20030004311A1 (en) * 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030022239A1 (en) 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins
NZ505500A (en) 1997-12-17 2002-12-20 Immunex Corp Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001007611A2 (en) 1999-07-26 2001-02-01 Genentech, Inc. Novel polynucleotides and method for the use thereof
EP1672070A3 (en) * 1999-12-01 2006-10-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20040034192A1 (en) * 2000-01-06 2004-02-19 Seishi Kato Human proteins having hyprophobic domains and dnas encoding these proteins
US20040219521A1 (en) * 2000-01-21 2004-11-04 Tang Y. Tom Novel nucleic acids and polypeptides
US20040038339A1 (en) 2000-03-24 2004-02-26 Peter Kufer Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
AU2001252621A1 (en) 2000-04-27 2001-11-12 Takeda Chemical Industries Ltd. Novel proetin and use thereof
MXPA02010787A (es) 2000-05-03 2003-07-14 Amgen Inc Peptidos modificados como agentes terapeuticos.
WO2002068615A2 (en) 2001-02-28 2002-09-06 Fred Hutchinson Cancer Research Center, Inc. Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
US6821522B2 (en) * 2001-05-31 2004-11-23 The Regents Of The University Of California Tumor Therapy
JP2005502335A (ja) 2001-08-08 2005-01-27 インサイト・ゲノミックス・インコーポレイテッド 細胞成長、分化および細胞死関連タンパク質
WO2003054152A2 (en) * 2001-12-10 2003-07-03 Nuvelo, Inc. Novel nucleic acids and polypeptides
AU2002238359A1 (en) 2002-03-04 2003-09-16 Shanghai Genomics, Inc. Tumor tag and the use thereof
WO2004022706A2 (en) 2002-09-04 2004-03-18 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor

Also Published As

Publication number Publication date
WO2003029436A3 (en) 2003-11-13
US7563450B2 (en) 2009-07-21
US20090274699A1 (en) 2009-11-05
US8129167B2 (en) 2012-03-06
EP1451333B1 (en) 2009-06-24
MXPA04003057A (es) 2005-06-20
EP1451333A4 (en) 2005-03-30
US20030195337A1 (en) 2003-10-16
AU2002340118B2 (en) 2007-09-13
EP1451333A2 (en) 2004-09-01
CA2462790A1 (en) 2003-04-10
DE60232742D1 (de) 2009-08-06
WO2003029436A2 (en) 2003-04-10
ATE434624T1 (de) 2009-07-15
JP2005523681A (ja) 2005-08-11

Similar Documents

Publication Publication Date Title
PL373594A1 (en) Ul16 binding protein 4
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
CA2120514A1 (en) Synthetic dna sequence having enhanced insecticidal activity in maize
MX9503362A (es) Nuevos anticuerpos br96 mutantes y equivalentes funcionales que reaccionan con carcinomas humanos.
AU2002360331A8 (en) Egviii endoglucanase and nucleic acids encoding the same
CA2266319A1 (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
EP2314604A3 (en) Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
WO2004043403A3 (en) Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
AU7001994A (en) Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof
AU8148398A (en) Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
DE69619808D1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
AU4375493A (en) Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
AU3711597A (en) A novel galanin receptor
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
WO2001068846A3 (en) Transcription activator of the cited family
EP1047710B1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
WO1998024896A3 (en) Muteins of obese protein
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
WO2000008145A3 (en) Novel genes in control of hematopoiesis
MXPA04000397A (es) Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.